Pharming Group N.V. (AMS: PHARM)
Netherlands
· Delayed Price · Currency is EUR
0.682
0.00 (0.00%)
Sep 4, 2024, 5:35 PM CET
Pharming Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 462 | 563 | 483 | 567 | 369 | 456 | |
Market Cap Growth | -16.25% | 16.70% | -14.77% | 53.44% | -18.98% | -17.49% | |
Enterprise Value | 427 | 586 | 498 | 488 | 308 | 437 | |
Last Close Price | 0.68 | 10.64 | 8.71 | 9.79 | 6.19 | 7.64 | |
PE Ratio | - | 16.95 | 15.02 | 16.05 | 20.07 | 100.97 | |
PS Ratio | 1.75 | 0.42 | 0.41 | 0.63 | 0.41 | 0.44 | |
PB Ratio | 2.24 | 1.80 | 1.52 | 1.88 | 1.34 | 1.66 | |
P/FCF Ratio | 11.79 | 119.00 | 20.77 | 39.07 | 4.15 | 29.20 | |
P/OCF Ratio | 10.99 | 72.87 | 18.34 | 33.89 | 3.99 | 23.61 | |
EV/Sales Ratio | 1.65 | 0.44 | 0.42 | 0.54 | 0.34 | 0.42 | |
EV/EBITDA Ratio | 9.25 | 9.71 | 7.72 | 9.95 | 12.82 | 21.58 | |
EV/EBIT Ratio | 9.95 | 10.42 | 8.21 | 10.44 | 14.30 | 25.10 | |
EV/FCF Ratio | -70.22 | 123.71 | 21.43 | 33.63 | 3.46 | 28.02 | |
Debt / Equity Ratio | 0.49 | 0.38 | 0.20 | 0.14 | 0.13 | 0.16 | |
Debt / EBITDA Ratio | 2.03 | 1.58 | 0.82 | 0.68 | 0.96 | 1.16 | |
Debt / FCF Ratio | 3.46 | 24.88 | 2.76 | 2.91 | 0.41 | 2.73 | |
Asset Turnover | 2.35 | 2.30 | 2.25 | 1.94 | 2.07 | 2.50 | |
Quick Ratio | 2.71 | 2.47 | 2.44 | 2.33 | 2.78 | 2.55 | |
Current Ratio | 2.78 | 2.59 | 2.53 | 2.40 | 2.90 | 2.67 | |
Return on Equity (ROE) | 10.31% | 10.20% | 9.93% | 11.44% | 6.39% | 0.05% | |
Return on Assets (ROA) | 5.80% | 6.07% | 7.23% | 6.29% | 3.11% | 2.61% | |
Return on Capital (ROIC) | 8.64% | 8.65% | 10.44% | 8.91% | 4.29% | 3.63% | |
Earnings Yield | -2.75% | 5.62% | 6.09% | 5.47% | 4.22% | 0.84% | |
FCF Yield | -1.31% | 0.84% | 4.81% | 2.56% | 24.09% | 3.42% | |
Dividend Yield | 5.50% | 5.17% | 6.31% | 4.60% | 4.85% | - | |
Payout Ratio | 90.54% | 87.58% | 77.17% | 48.94% | - | 330.59% | |
Buyback Yield / Dilution | 0.38% | 0.15% | -0.10% | 0.17% | - | 0.51% | |
Total Shareholder Return | 0.38% | 5.32% | 6.21% | 4.77% | 4.85% | 0.51% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.